With the peanut allergy patch for children, duration matters. Kids in a Phase 3 trial for 5 years had better tolerance, and no safety issues.| Allergic Living
The FDA has declined approval of neffy, the needle-free epinephrine nasal spray, calling for more study. Allergy families are disappointed.| Allergic Living
An expert panel votes to recommend FDA approval of ARS Pharma's neffy epinephrine nasal spray, as families speak of needle fears.| Allergic Living